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Abstract.  Keratinocyte attachment to fibronectin (FN) 
substrata was inhibited by the peptide Gly-Arg-Gly- 
Asp-Ser-Pro-Cys, but not by the variant peptide Gly- 
Arg-Gly-Glu-Ser-Pro. The RGDS-containing peptide 
did not inhibit keratinocyte adhesion to collagen.  Ker- 
atinocyte adhesion to FN substrata also was inhibited 
by polyclonal anti-FN receptor antibodies originally 
prepared against the  140-kD  FN receptors of Chinese 
hamster ovary (CHO) cells. Anti-CHO FN receptor 
antibodies did not, however, inhibit keratinocyte adhe- 
sion to collagen substrata.  A  monoclonal antibody 
designated VM-1 that was prepared against human 
basal keratinocytes inhibited keratinocyte adhesion to 
collagen but not to FN. Based on these results,  we 
conclude that keratinocytes have distinct FN and colla- 
gen receptors.  Experiments were performed to com- 
pare the expression of FN receptors on keratinocytes 
freshly isolated from skin and keratinocytes harvested 
from cell cultures.  Cells harvested from keratinocyte 
cultures were able to neutralize the inhibitory activity 
of anti-CHO FN receptor antibodies and were able to 
attach and  spread on anti-CHO FN receptor-coated 
substrata.  Cells freshly harvested from skin,  however, 
did not neutralize the antibodies, nor did they attach 
and spread on antibody-coated substrata.  To learn 
more about the biochemical nature of the keratinocyte 
FN receptors,  we performed immunoaftinity chroma- 
tography and immunoprecipitation  experiments using 
the anti-CHO FN receptor antibodies.  Extracts from 
metabolically radiolabeled,  10-d cultured keratinocytes 
contained FN receptors that had a  135-kD component 
under reducing conditions and  115- and  155-kD  com- 
ponents under nonreducing conditions.  Similar compo- 
nents were observed in extracts from surface-radio- 
labeled cells indicating that the FN receptors were 
expressed on keratinocyte cell surfaces.  On the other 
hand,  extracts from metabolically radiolabeled,  1-d 
cultured keratinocytes lacked intact FN receptors but 
contained a component that migrated at 48 kD under 
reducing conditions and 50 kD under nonreducing 
conditions. Because this fragment was not detected in 
surface-radiolabeled keratinocytes that were freshly 
isolated from skin,  it seems likely that the fragment 
was located inside the cells rather than on the cell sur- 
face. A  50-kD FN receptor fragment also was ob- 
served in extracts from 10-d cultured keratinocytes if 
leupeptin and pepstatin were omitted from the extrac- 
tion buffer.  The results suggested that human keratino- 
cytes cultured for 10 d express the  140-kD  class of FN 
receptors,  but that these receptors are not expressed on 
the surfaces of keratinocytes freshly isolated from 
skin.  Probably, the  140-kD  FN receptors of keratino- 
cytes in skin are synthesized and then rapidly de- 
graded cytoplasmically. The modulation of keratinocyte 
FN receptors is likely to be an important  feature of 
reepithelization during  wound repair. 
B 
ASAL keratinocytes  in unwounded  skin exist as non- 
motile cells attached  to a basement membrane that 
contains  laminin  and type IV collagen (17). During 
wound repair, however, these cells migrate over and through 
a fibronectin  (FN)~-coated matrix (7,  13) in the absence of 
laminin and type IV collagen (27). Although it had been sug- 
gested  that  laminin  was  the  adhesion  ligand  specific  for 
epidermal cells (33), other studies did not support this idea 
(11, 28). Detailed examination  of the adhesive properties of 
cultured  human  epidermal  cells  showed  that  FN  was  an 
1. Abbreviation  used in this paper:  FN,  fibronectin. 
adhesion  ligand  for these cells that promoted not only cell 
attachment and spreading, but also phagocytosis and motility 
(8, 20, 30, 31). 
In the course of our experiments,  we noticed that epider- 
mal cells freshly isolated from human  skin,  unlike cultured 
cells, were unable to attach to FN substrata in short-term (45 
min) assays (31). The onset of FN cell adhesion function was 
evident in epidermal cells harvested  and tested after 2-4 d 
of culture and reached a maximal level after 10 d of culture. 
Epidermal cells activated during  cell culture were found to 
be basal ketatinocytes based on indirect immunofluorescence 
staining with antikeratin antibodies and bullous pemphigoid 
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occurred in keratinocytes that migrated out of epidermal ex- 
plants (31). 
Activation of FN cell adhesion function also was measured 
during wound healing in vivo (29). In these studies, rabbit 
ear  epidermal cells were transplanted onto  full-thickness 
wound beds that had been prepared on the backs of the same 
rabbits. It was found that keratinocytes harvested from grafts 
showed a markedly increased ability to attach and spread on 
FN substrata compared with keratinocytes freshly harvested 
from ear skin. 
Studies performed to determine the specificity of epider- 
mal cell attachment showed that cells freshly harvested from 
skin were able to attach to substrata other than FN including 
laminin/type IV  collagen-containing basement membrane 
matrix produced by HR-9 cells and type I  collagen (34). 
Moreover,  unlike cell attachment to FN,  there was  little 
change in the ability of  cells to attach to these other substrata 
after the cells were cultured. Therefore, the activation of cell 
attachment for FN that occurred during epidermal cell cul- 
ture was specific. 
The above findings led us to believe that keratinocyte FN 
receptors were activated during wound repair and under cell 
culture conditions.  Although FN receptors of fibroblastic 
cells have been analyzed in detail (2, 4, 6, 15, 24, 32), little is 
known about the receptors of keratinocytes. Consequently, 
we became interested in learning more about human ker- 
atinocyte FN receptors. Toward this end, experiments were 
performed to test the effects of FN cell-binding domain pep- 
tides (1, 25) on keratinocyte adhesion. Also, we character- 
ized keratinocyte FN receptors using a polyclonal anti-FN 
receptor antibody that was prepared originally against Chi- 
nese hamster ovary (CHO) FN receptors and found to cross- 
react with several human cell lines (4).  The results of these 
studies are reported herein. 
Materials and Methods 
Cells 
Human skin was obtained from the Burn Center, University of Texas Health 
Science Center, Dallas, and human epidermal cells were prepared using 
Dispase II  (Boehringer Mannheim Biochemicals, Indianapolis, IN)  and 
trypsin treatment and cultured as described previously (29-31). The culture 
medium consisted of Dulbecco's modified Eagle's medium (DME, Gibco, 
Grand  Island,  NY)  supplemented with 20%  fetal  bovine serum  (FBS, 
Gibco), 20 mM Hepes buffer, 100 U/ml penicillin, 100 gg/ml streptomycin, 
0.25 I~g/ml fungizone, 10 ng/ml epidermal growth factor (Sigma Chemical 
Co., St.  Louis, MO),  10  .-9 M  cholera toxin (Sigma Chemical Co.), and 
0.4 Itg/ml hydrocortisone (Sigma Chemical Co.). For 5- or 10-d (confluen0 
cultures, cells freshly harvested from skin (1  x  107) in  15 ml of culture 
medium were plated on 75-cm  2 tissue culture flasks (Falcon Labware, Ox- 
nard, CA) and incubated at 37~  in a humidified incubator with 5% CO2. 
The first medium change was 2 d after initiating the cultures. Throughout 
the culture period, the medium was changed two to three times per week. 
Some experiments were performed with cells that were freshly harvested 
from skin or cultured for only 1 d. In this case, it was desirable to obtain 
a preparation enriched in basal keratinocytes, which account for only ,'-~30  % 
of the keratinocytes in skin hut account for ,080%  of keratinocytes in the 
5- or 10-d cultures (34). To obtain enriched preparation, freshly harvested 
cells (2  ￿  107) in 15 ml of culture medium were plated for 45 min on 75- 
cm  2 flasks previously coated with 50 Ixg/ml collagen as described previ- 
ously (34). 
Cells cultured on plastic or on collagen-coated plastic were harvested 
using the same combination of Dispase and trypsin treatment used to obtain 
cells from human skin. Prior to experiments, harvested cells were allowed 
to recover from enzyme treatments by incubation for 2 h at 37~  in culture 
medium. Epidermal cell preparations used in the experiments described in 
this paper were ,090% keratinocytes based on staining with antikeratin anti- 
bodies and 80% basal cells based on staining with bullous pemphigoid se- 
rum (31, 34). 
Materials and Preparation  of  Substrata 
FN was obtained from the New York Blood Center. FN-coated substrata 
were prepared as described previously (29-31) by incubating 35-ram tissue 
culture dishes (Falcon Labware) with 20 I~g/mi FN in phosphate-buffered 
saline (PBS) (10 mM Na phosphate, 150 mM NaCl, pH 7.2) and counter- 
coating the dishes with  1% heat-denatured bovine serum albumin (BSA) 
(crystallized, Miles Scientific, Naperville, IL). 
Collagen samples (3 mg/ml) (Vitrogen 100, Collagen Corp., Palo Alto, 
CA) were brought to physiological ionic strength with 10￿  PBS and neutral- 
ized with NaOH.  Collagen-coated substrata were prepared as before (34) 
by incubating tissue culture dishes (above) for 30 min at 37~  with 3 mi 
of DME containing 50 gg/ml neutralized collagen and rinsing wiih DME. 
Polyclonal antibodies to 140-kD receptors of CHO cells were isolated as 
described previously (4). The IgG fraction obtained by ammonium sulfate 
fractionation was passed through a gelatin-sepharose column to remove FN 
contaminating the preparation (10), and the absence of FN was confirmed 
by SDS-PAGE (data not shown). Antibody-coated substrata were prepared 
by incubating tissue culture dishes for 10 min at 22"C with 2.4 mg/mi anti- 
body in PBS followed by 1% heat-denatured BSA. 
Monoclonal VM-1 antibody hybridoma supernatant (22) was a generous 
gift from Dr. Vera Morhenn (Stanford Medical Center, Stanford, CA). Syn- 
thetic peptides Gly-Arg-Gly-Asp-Ser-Pro-Cys (GRGDSPC) and Gly-Arg- 
Gly-Glu-Ser-Pro (GRGESP) were purchased from Peninsula Laboratories, 
Inc., Belmont, CA. 
Cell  Attachment and Spreading  Assays 
Keratinocyte attachment and spreading ~,~re measured as before (29-31). 
Freshly harvested cells or harvested cultured cells (2  x  10  ~) in 2  ml of 
DME were incubated on the test substrata for 45 rain at 37~  in a humidified 
incubator with 5% CO2.  At the end of the incubations, the dishes were 
subjected to shaking at 150 rpm for 10 s on a reciprocating shaker (model 
R-2, New Brunswick Scientific Co., Inc., Edison, NJ), and nonattached 
cells were removed with a pipette. Cell attachment was quantified visually 
by counting 20 random 0.6-mm  2 microscopic fields and calculating the 
number of cells attached per dish. The percentage  of attached cells that were 
spread (with obvious cytoplasmic reorganization around the nucleus) was 
determined visually by counting 100-150 cells. Typically,  maximal attach- 
ment of keratinocytes in these short-term assays is 50-60 %, and 80% of the 
cells that attach are basal keratinocytes (34). 
Protein Determination 
Protein concentration was determined by the fluorescamine method using 
the fiuorescamine assay reagent according to the manufacturer's instructions 
(Roche Diagnostics, Nutley,  N J). BSA was used as the standard. 
Immunoabsorption 
Cells freshly harvested from skin or harvested from cell cultures (and al- 
lowed to recover for 2 h in growth medium) were fixed for 20 min at 22~ 
with 3 % formaldehyde in PBS, washed twice with PBS, treated for 10 rain 
at 22~  with PBS containing 1% BSA and 1% glycine, and washed twice 
again with PBS. Cells were resuspended in 0.1 ml of DME and incubated 
for 60 rain at 22~  with 2 mg of anti-CHO FN receptor IgG or nonimmune 
goat IgG. At the end of incubations, the samples were microfuged to remove 
the cells, and the supernatants were tested for their effects on epidermal cell 
adhesion to FN substrata. 
Immunoa~nity Chromatography 
Metabolically radiolabeled epidermal cells were obtained by incubating cell 
cultures for 16 h with 8 ml of methionine-deficient medium containing 20 
gCi/ml  [35S]methionine.  Each 75-cm  2 flask of cells was extracted with 
3 ml of cold NP-40 extraction buffer (137 mM NaCI,  1.5 mM KH2PO4, 
8 mM Na2HPO4,  2.7 mM KCI,  1% NP-40,  10% glycerol, 1 mM EDTA, 
2 mM Phenylmethylsulfonyl fluoride (PMSF), 1 lag/ml leupeptin, 1 lag/ml 
pepstatin, pH 8.0). After 1 min, cells were scraped from the flasks, and the 
flasks were washed with an additional 3 m! of extraction buffer. The pooled 
samples (usually  10 flasks per experiment, ~  x  107 radiolabeled cells) 
were incubated for 30 min at 4~  in extraction buffer after which insoluble 
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rotor,  DuPont-Sorvall,  Newtown,  CT). 
Molecules bound by polyclonal anti-CHO FN receptor antibodies were  I 
isolated by affinity chromatography. Cyanogen bromide-activated  Sepharose  0 
4B (Pharmacia Fine Chemicals, Piscataway, NJ) was coupled with immune  e" 
IgG or nonimmune goat IgG according to the manufacturer's  instructions  / 
(10 mg IgG/g gel). Before use, columns were washed with 15 ml of acetate  L 
buffer (0.1 M Na acetate, 0.5 M NaC1, pH 4.0) and 15 ml of running buffer 
(0.1 M  Tris,  0.5  M  NaC1, pH 8.0).  The NP-40 extracts of radiolabeled  E 
epidermal cells were chromatographed sequentially through 10 ml of Seph-  e- 
arose 2B (Pharmacia Fine Chemicals), 10 ml of nonimmune IgG-coupled 
Sepharose 4B, and 2 ml of immune lgG-coupled Sepharose 4B. The col- 
umns were washed with 200 mi of running buffer and eluted with 20 ml of 
0.1 M glycine-HCl  (pH 2.5). The eluted fractions were immediately titrated 
to pH 7-7.5 with Tris base and dialyzed exhaustively  against 0.005 M Tris 
HCI,  pH 7.4, and lyophilized. 
Immunoprecipitation 
Immunoprecipitation of ~25I surface-radiolabeled keratinocytes  with anti- 
CHO FN receptor antibodies was performed as has been described (4). 
Briefly, rabbit anti-goat IgG (Cooper Biomedical, Inc., Malvern, PA)-con- 
jugated protein A Sepharose 413 beads (Pharmacia Fine Chemicals) were 
preincubated with nonimmune IgG or anti-CHO FN receptor antibodies. 
Freshly isolated keratinocytes enriched for basal cells or keratinocytes har- 
vested from lO-d cultures (2  x  107) were surface radiolabeled  with 1 mCi 
Na[125I] using Iodo-Beads  (Pierce Chemical Co., Rockford,  IL) according 
to the manufacturer's directions and then extracted  with NP-40 extraction 
buffer (see above) for 30 min at 4"C. The extracts were centrifuged at 12,000 
g in a microfuge (model ll, Beckman Instruments, Inc., Fullerton, CA) for 
15 rain. Cell extracts first were incubated for 2 h at 4~  with nonimmune 
goat IgG-beads and then incubated overnight at 4~  with anti-CHO FN 
receptor beads. Finally, the beads were washed three times with NP-40 ex- 
traction buffer, once with PBS containing 0.5 M NaCl, and one more time 
with NP-40 extraction buffer. The immnnoprecipitated  materials associated 
with beads after the washing procedures were solubilized in sample buffer 
for electrophoresis and autoradiography. 
Electrophoresis and Fluorography 
Samples for electmphoresis were boiled for 3 rain in nonreducing sample 
buffer (62.5  mM Tris,  2% SDS,  10% glycerol,  0.01% bromophenol blue, 
pH  6.8)  or  reducing  sample  buffer  (same  as  above  plus  5%  mercap- 
toethanol). Electrophoresis was performed as previously  described using 
4-16 % acrylamide gradient slab gels containing a gradient of 3-8 M urea 
(16, 21). Gels for autoradiography  and fluorography  were prepared using 
AcrylAide (FMC Corp., Rockland,  ME) as the cross-linker instead of  N-N'- 
methylene-bis-acrylamide  and supported with GelBond-PAG film (FMC 
Corp.). After electrophoresis,  gels were fixed and stained with Coomassie 
Blue. Gels to be fluorographed were impregnated with En3Hance (contain- 
ing 2% glycerol)  for 2 h at 22~  Gels were dried in a 60*C oven and ex- 
posed to Kodak XAR-5 film on a Cronex intensifying  screen (Dupont Co., 
Wilmington, DE). 
Results 
Effect of  Peptides on Keratinocyte Adhesion 
The first series of experiments carried out were designed to 
learn whether keratinocytes attached to the same domain of 
FN that has been identified in attachment of fibroblasts. To 
accomplish this, we tested the effect of an Arg-Gly-Asp-Ser 
peptide on keratinocyte adhesion. Addition of GRGDSPC at 
concentrations ranging from 0.0625 to 1.0 mg/ml resulted in 
inhibition of both keratinocyte attachment and spreading on 
FN substrata (Fig.  1). The concentration required for half- 
maximal inhibition was between 0.125 and 0.250 mg/ml. In 
marked contrast, there was no inhibition of keratinocyte at- 
tachment or spreading on collagen substrata at any of the 
peptide concentrations tested (Fig.  1). Also, the substituted 
peptide GRGESP did not inhibit cell adhesion on FN or col- 
lagen substrata (data not shown). 
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Figure 1+ Effect of synthetic peptide Gly-Arg-Gly-Asp-Ser-Pro-Cys 
(GRGDSPC) on keratinocyte adhesion. Keratinocytes harvested from 
confluent cell cultures were tested for cell attachment and spreading 
on FN and collagen substrata in the presence of GRGDSPC at the 
concentrations indicated. The data shown are the averages +  SD 
from three separate experiments. Other details are in Materials and 
Methods. 
Effect of  Anti-CHO FN Receptor and VM-1 
Antibodies on Keratinocyte Adhesion 
The above results showed that human keratinocytes inter- 
acted with the RGDS-containing cell binding domain of FN. 
Also, we tested the effect of polyclonal anti-CHO FN recep- 
tor antibodies on keratinocyte adhesion. This antibody in- 
hibited the attachment and spreading of  human keratinocytes 
to FN substrata but not to collagen substrata (Fig. 2). Similar 
concentrations of nonimmune  goat IgG had  no effect on 
adhesion (data not shown). Conversely, the monoclonal anti- 
body VM-1 (22) inhibited human keratinocyte attachment to 
collagen but not to FN (Fig. 3). These results show that hu- 
man keratinocyte  adhesion to different substrata can be selec- 
tively inhibited with different antibodies. 
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Figure 2.  Effect of anti-CHO FN receptor antibodies on keratino- 
cyte adhesion to FN and collagen substrata. Keratinocytes harvested 
from confluent cell cultures  were tested for cell attachment and 
spreading on FN and collagen substrata in the presence of anti- 
CHO FN receptor antibodies at the concentrations indicated. Data 
shown are the averages  +  SD  from three separate experiments. 
Other details are in Materials and Methods. 
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Figure 3. Effects of VM-1 antibodies  on keratinocyte  adhesion to 
FN substrata.  Keratinocytes harvested  from confluent cell cultures 
were tested for cell attachment  and spreading  on FN and collagen 
substrata in the presence of VM-I antibodies  at the concentrations 
indicated.  Data shown are the averages +  SD from two separate ex- 
periments.  Other details  are in Materials  and Methods. 
Expression of FN Receptors on Keratinocytes 
Freshly Harvested  from Skin Compared with 
Cultured Keratinocytes 
The foregoing results suggested that keratinocytes possessed 
the 140-kD class of FN receptors because keratinocyte adhe- 
sion to FN was inhibited by anti-CHO FN receptor antibod- 
ies. To compare the expression of these FN receptor binding 
sites on the surfaces of keratinocytes freshly harvested from 
skin or harvested from cultures, quantitative immunoabsorp- 
tion-neutralization experiments were performed.  Keratino- 
cytes freshly harvested  from skin or harvested  from con- 
fluent cell cultures (by the same combination of Dispase and 
trypsin treatment) were fixed, and various cell numbers were 
incubated  with  anti-CHO  FN  receptor  antibodies.  Subse- 
quently, the cells were removed and the remaining superna- 
tants were tested for their abilities to inhibit adhesion of cul- 
tured keratinocytes to FN (Fig.  4). 
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Figure 4.  Absorption of anti-CHO  FN  receptor antibody with 
freshly isolated and cultured keratinocytes.  Samples of anti-CHO 
FN receptor antibodies were incubated with fixed keratinocytes that 
were freshly harvested from skin or harvested from cell cultures as 
indicated.  After removing the cells, the ability of  the remaining an- 
tibody preparation to inhibit keratinocyte  adhesion to FN substrata 
was tested.  Data shown are the averages  +  SD from two separate 
experiments.  Other details  are in Materials  and Methods. 
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Figure 5. Attachment of freshly isolated and cultured keratinocytes 
on FN, collagen,  and anti-CHO FN receptor substrata.  Keratino- 
cytes, freshly harvested from skin or harvested from 5- or 10-d cell 
cultures,  were tested for cell attachment on the substrata indicated. 
Data shown are the averages +  SD from two separate experiments. 
Other details  are in Materials  and Methods. 
In the absence of cells or with  104 cells, there was no ab- 
sorption of inhibitory activity. Above 105 cells, the cultured 
keratinocytes  absorbed  inhibitory  activity  from  the  anti- 
CHO FN receptor preparation,  and the inhibitory activity 
was  neutralized  completely  with  107  cells.  On  the  other 
hand, cells freshly harvested from skin do not absorb inhibi- 
tory activity from the anti-CHO FN receptor preparation. 
This result suggested that FN receptors were expressed on 
the surfaces of cultured keratinocytes but not on the surfaces 
of keratinocytes freshly harvested from skin. 
Keratinocyte attachment and spreading assays on substrata 
coated  with  anti-CHO  FN  receptor  IgG  also  were  per- 
formed. Cells freshly isolated from skin were unable to at- 
tach to fibronectin or anti-CHO FN receptor antibody sub- 
strata, but these cells were able to attach to collagen substrata 
(Fig. 5). Cells harvested from 5- or 10-d-old cultures, how- 
ever,  showed markedly increased attachment to fibronectin 
and anti-CHO FN receptor substrata although the extent of 
cell  attachment  to  collagen  substrata  did  not  change.  In- 
creased cell spreading on anti-CHO FN receptor antibodies 
was observed over the same time that cell spreading on FN 
and collagen substrata increased (Fig. 6). These results are 
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Figure 6. Spreading  of freshly isolated and cultured keratinocytes 
on FN, collagen, and anti-CHO FN receptor-coated substrata.  Ker- 
atinocytes, freshly harvested from skin or harvested from 5- or 10-d 
cell cultures,  were tested  for cell spreading  on the substrata  indi- 
cated. Data shown are the averages + SD from two separate experi- 
ments.  Other details  are in Materials  and Methods. 
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keratinocytes analyzed by SDS-PAGE under  reducing conditions. 
Metabolically radiolabeled keratinocytes were harvested from 10-d 
(A-C) or 1-d (D-F)  cultures. Cells were extracted with NP-40 (A, 
D). Most of the radiolabeled cell components passed through an 
anti-CHO FN receptor antibody column (B, E). With the extracts 
of cells harvested from 10-d cultures, a 135-kD component bound 
to the column and was eluted by glycine-HCl (C). With the extracts 
from the 1-d cultures, a 48-kD component bound the column (F). 
Specimens  for electrophoresis  were prepared  in reducing sample 
buffer. 10,000 cpm were loaded on each lane. Other details are in 
Materials  and Methods.  Mr standards given in kilodaltons. 
Figure 8.  Fibronectin  receptors  from metabolically  radiolabeled 
keratinocytes  analyzed by SDS-PAGE under  nonreducing  condi- 
tions.  Same as Fig.  7 except specimens for electrophoresis  were 
prepared  in nonreducing sample buffer. With the extracts of cells 
from  10-d cultures,  115- and  155-kD components  bound  to  the 
colunm and were eluted by glycine-HC1  (C). With the extracts from 
the 1-d cultures, a 50-kD component bound the column (F). Other 
details are in Materials  and Methods. Mr standards given in kilo- 
daltons. 
consistent  with the antibody neutralization  studies  (above) 
and suggest that FN receptors are expressed on cultured ker- 
atinocytes but not on keratinocytes freshly harvested from 
skin. 
Immunoa~nity Chromatography of  Human 
Keratinocyte FN Receptors 
To learn more about the biochemical nature of keratinocyte 
FN receptors, cell extracts were analyzed by immunoaflinity 
chromatography. In these experiments, we used cells from 
10-d cultures and cells from 1-d cultures that have no detect- 
able FN receptor function (31,  34).  Metabolically radiola- 
beled keratinocytes were extracted with  NP-40 buffer and 
chromatographed sequentially on native Sepharose, nonim- 
mune IgG-coupled Sepharose, and anti-CHO FN receptor 
IgG-coupled Sepharose columns.  Most of the starting cell 
extract protein passed through the columns. After washing, 
the columns were eluted with 0.1 M glycine-HC1, and no ra- 
dioactive components could  be recovered from the  native 
Sepharose or nonimmune columns.  There was, however, a 
small  but  reproducible  amount  of  material  representing 
<0.02 % of the starting preparation that was eluted from the 
immune column. 
Analysis of column fractions by SDS-gel electrophoresis 
under reducing conditions showed a large number of compo- 
nents ranging from <45 kD to >300 kD. The profile of these 
components was similar although not identical in the extracts 
from keratinocytes cultured for 10 d  (Fig.  7,  lane A) com- 
pared with extracts from cells that were cultured  1 d  (Fig. 
7, lane D). Also, the profiles of unbound material that passed 
through the immune column were essentially identical to the 
starting cell extracts (Fig.  7, lane B vs. A and E  vs. D). In 
the extract from cells cultured 10 d, there was a single com- 
ponent of 135 kD that bound to and was eluted from the im- 
mune column (Fig. 7, lane C).  In marked contrast, the ex- 
tract  from cells  cultured  1  d  did  not  contain  the  135-kD 
molecule.  Rather,  they  contained  a  lower-molecular-mass 
component  of 48  kD  that  was  eluted  from  the  immune 
column (Fig. 7, lane F).  Specimens also were analyzed by 
SDS-gel electrophoresis under nonreducing  conditions.  In 
this case, the 135-kD component from 10-d cultured keratin- 
ocytes was seen to migrate as two components of 115 and 155 
kD (Fig. 8, lane C). The lower-molecular-mass component 
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cytes cultured  10 d.  Same as Fig. 7 (lanes A-C) except pepstatin 
and leupeptin were omitted from the NP-40 extraction buffer. High- 
molecular-mass components were absent from the cell extracts (A) 
and the fraction that did not bind to the  affinity column  (B).  A 
48-kD component bound to the affinity column and was eluted by 
glycine-HC1 (C). 50,000 cpm were loaded on lanes A and B; 5,000 
cpm were loaded  on lane  C.  Other  details are in Materials  and 
Methods.  Mr standards given in kilodaltons. 
from 1-d cultured keratinocytes was present and had a molec- 
ular mass of 50 kD (Fig.  8, lane F).  These results indicate 
that  10-d  cultured human keratinocytes have FN receptors 
similar to those found in mammalian fibroblasts (4, 24). On 
the other hand,  1-d cultured keratinocytes, which have been 
shown to lack normal FN receptor function, appeared to lack 
intact FN receptors. 
While working out optimal extraction conditions with cul- 
tured keratinocytes, we found that the cell extracts had a high 
level of endogenous protease activity. Consequently,  if we 
added only PMSF to the extraction buffer instead of PMSF, 
leupeptin, and pepstatin, then the high-molecular-mass com- 
ponents in the keratinocyte extract were lost (Fig. 9, lane A 
compared with Fig. 7, lane A), and the predominant compo- 
nent that was eluted from the immune column was ,o50 kD 
(Fig. 9, lane C). This finding indicated that the 48-kD com- 
ponent found in the extracts from 1-d cultures (Fig. 7, lane 
F) might be a proteolytic fragment of 140-kD FN receptors. 
Immunoprecipitation of  Human Keratinocyte 
FN Receptors 
To confirm that the  keratinocyte FN receptors detected  in 
studies with metabolically radiolabeled cells were expressed 
at the cell surface,  immunoprecipitation studies  were per- 
formed with surface-radiolabeled keratinocytes. In addition 
to cells from 10-d cultures, cells freshly isolated from skin 
and enriched for basal ceils were tested.  The keratinocytes 
were radioiodinated,  extracted with NP-40 buffer, and im- 
munoprecipitated sequentially with nonimmune IgG-beads 
and anti-CHO FN receptor antibody beads. 
Figure 10. Fibronectin receptors from radioiodinated keratinocytes 
analyzed by SDS-PAGE. Radioiodinated keratinocytes were pre- 
pared with cells harvested from 10-d cultures (A, B, E, F) or cells 
freshly isolated from skin and enriched in basal keratinocytes (C, 
D, G, H). Radioiodinated cells were extracted with NP-40 and im- 
munoprecipitated sequentially with nonimmune goat IgG beads (B, 
D, F, H) followed by anti-CHO FN receptor antibody beads (A, C, 
E, G). From the extracts of  cells harvested from 10-d  cultures, com- 
ponents were specifically immunoprecipitated that migrated with a 
molecular mass of 140 kD under reducing conditions (A) and 120 
and 160 kD under nonreducing conditions (E). No specific compo- 
nents were detected by immunoprecipitation of the extracts of cells 
freshly isolated from skin (C, G). Specimens for electrophoresis 
were prepared in reducing  sample buffer (A-D) or nonreducing 
sample buffer (E-H). 5,000 cpm were loaded on each lane. Other 
details are in Materials and Methods. Mr standards given in kilo- 
daltons. 
Keratinoctyes from radioiodinated  10-d cell cultures had 
cell surface components that were specifically immunopre- 
cipitated by anti-CHO FN receptor antibody beads.  These 
components had molecular masses of 140 kD under reducing 
conditions (Fig.  10, lane A) and 120 and 160 kD under non- 
reducing conditions (Fig.  10, lane E),  which indicated that 
the FN receptors detected in metabolically radiolabeled cells 
were expressed on the cell surface. On the other hand, the 
lower-molecuar-mass FN receptor fragment observed in the 
extracts  of metabolically  radiolabeled,  1-d  cultured  kera- 
tinocytes was not detected by immunoprecipitation of sur- 
face-labeled,  freshly isolated keratinocytes.  It is  possible, 
therefore, that FN receptors are synthesized in freshly iso- 
lated keratinocytes, but degraded before they reach the cell 
surface. 
Discussion 
The purpose of our studies was to analyze FN receptors of 
human  keratinocytes.  We  found  that  the  FN  receptors  of 
these cells recognized the RGDS-containing, cell-binding do- 
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hibited by the peptide Gly-Arg-Gly-Asp-Ser-Pro-Cys,  but not 
by  the  variant  peptide  Gly-Arg-Gly-Glu-Ser-Pro. Similar 
findings have been made for a variety of other cell types in- 
cluding fibroblasts, platelets, and macrophages (1, 25).  In- 
terestingly, the RGDS-containing peptide did not inhibit ker- 
atinocyte adhesion to collagen, and others recently reported 
that a very similar peptide was a poor inhibitor of human os- 
teosarcoma adhesion to collagen (9).  These results are con- 
sistent with the idea that cell adhesion to native collagen is 
independent of fibronectin, which we suggested for fibro-. 
blasts some time ago (14) and was subsequently confirmed 
by others (26). This idea also is supported by the result that 
keratinocytes freshly harvested from skin are able to attach 
to collagen substrata but not to FN substrata (34). 
Keratinocyte adhesion to FN substrata also was inhibited 
by a polyclonal anti-CHO FN receptor antibody. Previously 
(4), the anti-CHO FN receptor antibody was shown to be 
related to antibodies recognizing the  ll0-160-kD adhesion 
protein complex of chick fibroblasts (6,  15) and the 140-kD 
FN receptor of human osteosarcoma cells (24).  In our ex- 
periments, we found that the anti-CHO FN receptor anti- 
body did not inhibit keratinocyte adhesion to collagen sub- 
strata, which is further evidence that this antibody is very 
selective for FN-mediated cell adhesion (3, 4). On the other 
hand, the monoclonal antibody VM-1 inhibited cell attach- 
ment to collagen but not to FN substrata, further supporting 
a role for different  cell receptors in adhesion to FN and colla- 
gen substrata. 
Both the antibody neutralization experiments and kera- 
tinocyte attachment and spreading experiments on substrata 
coated with anti-CHO FN receptor antibodies led to the con- 
clusion that FN receptors are expressed on cultured keratino- 
cytes but  not  on  keratinocytes in  unwounded skin.  This 
difference was unlikely to be accounted for by differences in 
the methods for preparing the cells because the enzyme treat- 
ments used to harvest cells were the same for skin and for 
cell cultures, and the harvested cells were allowed to recover 
in medium for 2 h before they were tested. 
The biochemical nature of keratinocyte FN receptors was 
analyzed by immunoaffinity chromatography and immuno- 
precipitation experiments using the anti-CHO FN receptor 
antibodies. Extracts from metabolically radiolabeled,  10-d 
cultured  keratinocytes contained  typical  mammalian  FN 
receptors (4, 24) that had a 135-kD component under reduc- 
ing conditions and 115- and 155-kD components under non- 
reducing conditions. Similar components were observed in 
extracts from surface-radiolabeled cells indicating that the 
FN receptors were expressed on keratinocyte cell surfaces. 
On the other hand, extracts from metabolically radiolabeled, 
l-d cultured keratinocytes lacked intact FN  receptors  but 
contained a component that migrated in SDS-PAGE at 48 kD 
under reducing conditions and 50 kD under nonreducing 
conditions. A similar component also was observed in ex- 
tracts from 10-d cultured keratinocytes if leupeptin and pep- 
statin were omitted from the extraction buffer. This intrigu- 
ing  observation  suggested that  1-d cultured  keratinocytes 
contain a proteolytic fragment of FN receptors. Because this 
fragment was not detected in surface-radiolabeled keratino- 
cytes that were freshly isolated from skin, it seems likely that 
the fragment was located inside the cells rather than on the 
cell surface. 
The above results suggest a molecular explanation for the 
functional studies described in this paper and previously. 
That is, human keratinocytes cultured for 10 d express the 
140-kD class of FN receptors, but these receptors are not ex- 
pressed on the surfaces of  keratinocytes freshly isolated from 
skin. Probably, the 140-kD FN receptors of keratinocytes in 
skin  are  synthesized and  then  degraded  cytoplasmically. 
Modulation of FN receptor expression in cultured keratino- 
cytes is consistent with the idea that these receptors are acti- 
vated during wound repair as discussed at the beginning of 
this article. This activation may be an essential aspect of 
wound repair in that a  FN matrix has been implicated in 
epidermal migration as was discussed elsewhere (12). In this 
regard, it is worthwhile pointing out that topical application 
has been reported to promote epithelialization of nonhealing 
corneal ulcers (18, 19) and nonhealing venous stasis ulcers 
(35). 
Finally, it should be noted that developmental changes in 
the expression of FN receptors also have been reported. In 
murine erythroleukemia cells, for instance, it was found that 
the  140-kD FN receptors disappeared after dimethyl sulf- 
oxide-induced differentiation of these cells (23).  Consistent 
with this finding, reticulocytes but not erythrocytes from pe- 
ripheral blood express the 140-kD receptors. Thus, loss of 
the receptors may be a feature of terminal differentiation  dur- 
ing hematopoiesis. In another study, it was found that the 
140-kD  class of FN receptors  was present on embryonic 
chick lung cells, but markedly reduced in differentiated cells 
except smooth muscle (5). Future studies will be necessary 
to clarify the molecular mechanisms that control develop- 
mental changes in FN receptor expression and the modula- 
tion of FN receptor expression during wound repair. 
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